Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-001035
Filing Date
2020-01-10
Accepted
2020-01-10 20:02:06
Documents
1
Period of Report
2020-01-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6807
  Complete submission text file 0000899243-20-001035.txt   8124
Mailing Address C/O DICERNA PHARMACEUTICALS, INC 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
ROSSKAMP RALF (Reporting) CIK: 0001266625 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 20522348

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations